RJ Bio-Tech

₹3.4 0 | 0%

WEBSITE BSE:536456 NSE : RJ BIOTECH 01 Apr, 00:00

Market Cap ₹3 Cr.

Stock P/E 1.4

P/B -

Current Price ₹3.4

Book Value ₹ 0

Face Value 10

52W High ₹5

Dividend Yield 0%

52W Low ₹ 3.1

Edit Ratio

RJ Bio-Tech Research see more...

Overview Inc. Year: 2005Industry: Agriculture

RJ Bio-Tech Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

RJ Bio-Tech Quarterly Results

#(Fig in Cr.)	Jun 2014	Sep 2014	Dec 2014	Mar 2015	Jun 2015	Sep 2015	Dec 2015	Mar 2016
Net Sales	18	5	7	2	15	11	6	4
Other Income	0	0	0	0	0	0	0	0
Total Income	18	5	7	2	15	11	6	4
Total Expenditure	14	4	6	2	13	7	4	6
Operating Profit	3	1	2	-0	2	4	2	-3
Interest	1	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0
Profit Before Tax	2	0	1	-2	1	3	1	-4
Provision for Tax	0	0	0	0	0	0	0	0
Profit After Tax	2	0	1	-2	1	3	1	-4
Adjustments	-2	-0	-1	2	-1	-3	-1	4
Profit After Adjustments	0	0	0	0	0	0	0	0
Adjusted Earnings Per Share	2.6	0.1	0.7	-1.8	1.6	3.4	1.2	-3.7

RJ Bio-Tech Profit & Loss

#(Fig in Cr.)	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	TTM
Net Sales	16	20	29	32	36	16	9	10	13	16	14	36
Other Income	0	0	0	0	0	0	0	0	0	0	1	0
Total Income	16	20	29	32	36	16	9	10	13	16	15	36
Total Expenditure	13	16	23	26	30	27	17	17	17	28	13	30
Operating Profit	3	4	6	6	6	-11	-8	-7	-3	-13	2	5
Interest	2	2	3	4	3	4	4	4	1	0	6	4
Depreciation	0	0	0	1	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	-0	-0	0	0	0	0	-9	0	0	-3	-0	0
Profit Before Tax	1	1	3	1	2	-15	-21	-12	-4	-16	-4	1
Provision for Tax	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Tax	1	1	3	1	2	-15	-21	-12	-4	-16	-4	1
Adjustments	0	0	0	0	0	0	0	0	0	0	-5	-1
Profit After Adjustments	1	1	3	1	2	-15	-21	-12	-4	-16	-9	0
Adjusted Earnings Per Share	0	0	3	1.5	2.4	-15.9	-21.9	-12.2	-4.4	-16.6	-4.3	2.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-13%	12%	-3%	-1%
Operating Profit CAGR	0%	0%	0%	-4%
PAT CAGR	0%	0%	0%	NAN%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-18%	-23%	-26%	-19%
ROE Average	0%	0%	0%	-3%
ROCE Average	0%	-79%	-64%	-26%

RJ Bio-Tech Balance Sheet

#(Fig in Cr.)	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Shareholder's Funds	11	14	22	24	26	11	-10	-21	-26	-41	-50
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	3	3	2	2	0	1	5	5	5	4	3
Other Non-Current Liabilities	1	0	1	1	1	1	1	1	1	1	1
Total Current Liabilities	23	22	32	34	33	34	39	43	45	43	48
Total Liabilities	39	41	58	61	60	48	35	28	25	6	2
Fixed Assets	3	3	3	2	2	2	2	2	2	2	2
Other Non-Current Assets	0	0	0	1	1	1	1	1	0	0	0
Total Current Assets	32	35	52	56	55	44	32	24	22	4	0
Total Assets	39	41	58	61	60	48	35	28	25	6	2

RJ Bio-Tech Cash Flow

#(Fig in Cr.)	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Opening Cash & Cash Equivalents	1	1	0	1	0	-0	0	-0	0	-0	0
Cash Flow from Operating Activities	-4	4	-5	2	6	0	-3	1	1	2	-5
Cash Flow from Investing Activities	-3	-2	-2	-2	-1	-1	-1	-1	-1	-0	0
Cash Flow from Financing Activities	8	-3	8	-1	-5	1	3	-0	-0	-2	5
Net Cash Inflow / Outflow	0	-1	0	-0	-0	0	-0	0	-0	0	-0
Closing Cash & Cash Equivalent	1	0	1	0	-0	0	-0	0	-0	0	0

RJ Bio-Tech Ratios

#	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Earnings Per Share (Rs)	0	0	3.03	1.55	2.4	-15.86	-21.93	-12.18	-4.39	-16.56	-4.28
CEPS(Rs)	1.43	2.37	3.38	2.17	2.74	-15.64	-21.74	-12.02	-4.29	-16.47	-4.21
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	0	0	21.13	22.83	25.54	10.13	-11.5	-23.63	-28.1	-43.5	-53.17
Core EBITDA Margin(%)	20	20.13	20.37	17.84	16.8	-71.59	-90	-72.94	-26.02	-79.89	9.46
EBIT Margin(%)	17.61	18.35	19.22	15.98	15.9	-72.53	-189.91	-73.08	-25.19	-99.26	12.76
Pre Tax Margin(%)	4.99	6.57	10.01	4.62	6.34	-95.42	-233.67	-113.98	-31.06	-99.28	-29.14
PAT Margin (%)	3.37	6.57	10.01	4.62	6.31	-95.42	-233.67	-113.98	-31.06	-99.28	-29.14
Cash Profit Margin (%)	5.72	8.33	11.16	6.49	7.21	-94.11	-231.55	-112.5	-30.33	-98.7	-28.65
ROA(%)	1.64	3.3	5.83	2.46	3.76	-27.96	-50.28	-36.69	-15.63	-100.28	-104.09
ROE(%)	8.03	13.14	18.15	7.03	9.91	-88.93	0	0	0	0	0
ROCE(%)	11.57	12.02	14.47	10.86	11.73	-25.86	-51.57	-32.76	-19.75	-218.35	0
Receivable days	98.74	137.03	127.64	158.15	202.96	497.38	731.32	480.92	237.13	94.72	14.52
Inventory Days	422.65	369.31	310.89	340.38	305.79	617.29	761.77	491.48	380.6	179.09	0
Payable days	77.92	53.48	74.85	114.98	62.87	63.66	122.42	173.18	161	40.89	18.67
PER(x)	0	0	9.89	16.04	19.19	0	0	0	0	0	0
Price/Book(x)	0	0	1.42	1.09	1.8	2.47	-2.13	-0.82	-0.46	-0.15	-0.1
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	1.62	1.34	1.84	1.58	1.9	3.39	6.82	5.88	4.05	2.95	4
EV/Core EBITDA(x)	8.09	6.65	9.01	8.83	11.32	-4.73	-7.68	-8.22	-16.05	-3.69	27.91
Net Sales Growth(%)	19.73	23.33	44.48	10.42	13.55	-56.26	-43.75	14.35	32.06	18.24	-12.02
EBIT Growth(%)	21.34	28.52	51.31	-8.22	13.02	-299.62	-47.87	56.2	54.4	-365.06	111.31
PAT Growth(%)	31.55	140.27	120.35	-49.04	55.04	-761.74	-38.29	44.47	63.95	-277.31	74.18
EPS Growth(%)	0	0	0	-49.04	55.04	-761.75	-38.29	44.47	63.95	-277.31	74.18
Debt/Equity(x)	2.56	1.7	1.24	1.24	1.03	3.09	-3.41	-1.84	-1.57	-0.98	-1.01
Current Ratio(x)	1.41	1.54	1.61	1.63	1.68	1.27	0.81	0.56	0.49	0.09	0.01
Quick Ratio(x)	0.54	0.64	0.73	0.73	0.78	0.58	0.46	0.25	0.17	0.06	0.01
Interest Cover(x)	1.4	1.56	2.09	1.41	1.66	-3.17	-4.34	-1.79	-4.3	-6943.08	0.3
Total Debt/Mcap(x)	0	0	0.87	1.14	0.57	1.25	1.6	2.26	3.43	6.32	10.35

RJ Bio-Tech Shareholding Pattern

#	Sep 2017	Mar 2018	Sep 2018	Mar 2019	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022
Promoter	60.29	60.29	60.29	60.29	60.29	60.29	60.29	60.29	60.32	60.32
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	39.71	39.71	39.71	39.71	39.71	39.71	39.71	39.71	39.68	39.68
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Sep 2017	Mar 2018	Sep 2018	Mar 2019	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022
Promoter	0.57	0.57	0.57	0.57	0.57	0.57	0.57	0.57	0.57	0.57
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.38	0.38	0.38	0.38	0.38	0.38	0.38	0.38	0.38	0.38
Others	0	0	0	0	0	0	0	0	0	0
Total	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95

Pros

Debtor days have improved from 40.89 to 18.67days.
Company has reduced debt.
Company is almost debt free.

Cons

Company has a low return on equity of 0% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

RJ Bio-Tech News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 3400/-

Indian Potash

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

RJ Bio-Tech

Add Watchlist

RJ Bio-Tech Research see more...

Overview Inc. Year: 2005Industry: Agriculture

RJ Bio-Tech Share Price

Alert Data

Quarterly Price

Peer Comparison

RJ Bio-Tech Quarterly Results

RJ Bio-Tech Profit & Loss

Growth Rates

RJ Bio-Tech Balance Sheet

RJ Bio-Tech Cash Flow

RJ Bio-Tech Ratios

RJ Bio-Tech Shareholding Pattern

RJ Bio-Tech News

Top Unlisted Companies & InstaBuy Companies

Indian Potash

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!